IMPACT OF GOVERNMENT POLICY AND RATIONALITY OF THE SMOKER TO THE CIGARETTE CONSUMPTION IN INDONESIA
Hasanuddin Economics and Business Review · 2018
DOI: 10.26487/hebr.v1i3.1369 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hasanuddin Economics and Business Review, 2018. Verfasst von Noor Syaifuddin. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Even though there is high need of the excise revenue from a cigarette, but the government of Indonesia needs to take into account the long run effect of cigarette to the people. There are poverty, health and education issues relating to the cigarette consumption. Therefore, the government intervention can help people to curb the cigarette consumption. This study attempts to find the impact of the government policy through the excise tariff policy, and the rationality of the smoker to the cigarette consumption in Indonesia. This study recommends the government intervention in order to control the cigarette consumptions in Indonesia by pushing the cigarette price and making cigarette less affordable for less rationale smoker (the young and poor people). Secondly, the government can take an action in delimiting the access of cigarette advertising and educate people about the danger of cigarette to the people.
Zitieren
APA
Syaifuddin, N. (2018). IMPACT OF GOVERNMENT POLICY AND RATIONALITY OF THE SMOKER TO THE CIGARETTE CONSUMPTION IN INDONESIA. Hasanuddin Economics and Business Review. https://doi.org/10.26487/hebr.v1i3.1369
Vancouver
Syaifuddin N. IMPACT OF GOVERNMENT POLICY AND RATIONALITY OF THE SMOKER TO THE CIGARETTE CONSUMPTION IN INDONESIA. Hasanuddin Economics and Business Review. 2018. doi:10.26487/hebr.v1i3.1369
BibTeX
@article{Syaifuddin2018,
author = {Syaifuddin, Noor},
title = {IMPACT OF GOVERNMENT POLICY AND RATIONALITY OF THE SMOKER TO THE CIGARETTE CONSUMPTION IN INDONESIA},
journal = {Hasanuddin Economics and Business Review},
year = {2018},
doi = {10.26487/hebr.v1i3.1369}
}
EUVIMED